Background: Stroke survivors are inclined to consciously control their movements, a phenomenon termed "reinvestment". Preliminary evidence suggests reinvestment to impair patients' motor recovery. To investigate this hypothesis, an instrument is needed that can reliably assess reinvestment post-stroke. Therefore, this study aimed to validate the MovementSpecific Reinvestment Scale within inpatient stroke patients.
Introduction
Many individuals with stroke feel they need to consciously control their movements in order to ensure successful movement execution. This phenomenon is termed 'reinvestment': 177 attempting to consciously control movements by reinvesting explicit movement-related knowledge. Patients' inclination to reinvest may in part be due to the nature of instructions and feedback they receive during rehabilitation therapy -often directing their attention to how they should execute their movements. 43, 178 Also, deviant movement patterns due to motor impairments may trigger heightened self-consciousness after stroke. 179 Accumulating evidence suggests that a strong tendency to reinvest may worsen rather than improve the motor abilities of patients with stroke. For instance, healthy adults who rely on conscious motor control demonstrate inferior motor performance and learning, 57 and are more susceptible to experience skill-breakdown in dual-task 86 and high-pressure situations 93 compared to people who do not (or to a lesser extent). Also, reinvestment has been associated with an increased risk of falling in healthy elderly. 180 In line with these findings, chronic community-dwelling patients with stroke who are more predisposed to reinvest exhibit greater functional impairments. 28 This has triggered Orrell and co-workers to speculate that heightened reinvestment may impair motor recovery post-stroke. However, as this relationship is merely correlative, the presumed causality still needs to be established (i.e., an alternative explanation would be that patients with more severe motor impairments are more strongly triggered to reinvest, but that this increased reinvestment in itself does not exacerbate these impairments). Gaining insight into the role of reinvestment in motor learning post-stroke may help therapists select appropriate motor learning interventions for individual patients. Specifically, it will help them decide whether they should reduce patients' reliance on conscious motor control -for instance by the use of implicit motor learning strategies like errorless learning 107 or analogy learning 54 -or, alternatively, whether they should tune in to patients' preferences -for instance by encouraging conscious control of movement in patients with a pronounced inclination to reinvest.
To elucidate the putative role of reinvestment in motor rehabilitation after stroke, and to help therapists to reliably gauge reinvestment preferences of stroke patients, we first need a measure that allows reliable assessment of reinvestment already from the start of rehabilitation. One such measure could be the Movement-Specific Reinvestment Scale (MSRS) . 181 The MSRS is a self-report measure that comprises 10 statements about moving in general, with 5 statements referring to the subscale of Movement Self-Consciousness (MS-C; e.g., 'I am concerned about what people think about me when I'm moving'), and the other 5 referring to the Conscious Motor Processing subscale (CMP; e.g., 'I try to think about my movements when I carry them out'). Both a dichotomous (disagree/agree) and 6-point Likert Scale English language version (ranging from 'strongly disagree' to 'strongly agree') have been validated for use in healthy adults, particularly in the context of sports. 180, 181 As of yet, it is unclear whether the MSRS is of sufficient psychometric quality to be suitable to measure reinvestment of rehabilitating stroke patients. A recent study 29 has reported (a Dutch translation of ) the dichotomous version of the MSRS to have sufficient test-retest reliability (ICC = .85) when administered within a relatively small group (n=45) of chronic communitydwelling individuals with stroke (M = 2.7 years since stroke). While promising, several issues warrant further investigation before the MSRS can be applied within a clinical stroke population. First, and most importantly, Kleynen et al. 29 neither investigated the structural and construct validity of the MSRS, nor did they report on the internal consistency of its two subscales. Second, it is unclear whether test-retest values obtained within a chronic stroke population are applicable to individuals involved in clinical rehabilitation. Both motor 182 and cognitive functioning 183 often improve rapidly during the clinical rehabilitation period, possibly resulting in less 'stable' reinvestment tendencies. Finally, considerable measurement error was reported by Kleynen et al. 29 This might be due to their use of dichotomous answer possibilities, as scales with less than 5-answer options seem unfit to detect small clinically significant differences.
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This study aimed to address the issues outlined above, through comprehensive assessment of the validity and reliability of a 6-point Likert scale version of the MSRS for use in an inpatient stroke population (<1 year post-stroke) and healthy peers. For the purpose of this study, we used a Dutch translation of the original English MSRS 181 Structural validity of the MSRS was assessed by means of confirmatory factor analysis. Its construct validity was tested by assessing whether patients with stroke have significantly higher MSRS scores than healthy peers (as in Orrell et al. 28 ). Reliability tests included test-retest reliability, internal consistency, standard error of measurement (SEM) and minimal detectable change.
Methods

Participants
One-hundred inpatient individuals with stroke and 100 age-matched healthy controls participated in this study. This sample size was based on the assumption that for confirmatory factor analysis a subject-to-variable ratio of 10 is sufficient. 185 Patients were recruited in the Dutch rehabilitation centres Heliomare in Wijk aan Zee and Aardenburg in Doorn. Controls were recruited in the community. Recruitment took place across three measurement periods (November 2013 -January 2014 , May 2014 -July 2014 , and September 2014 -October 2014 .
Patients with stroke were eligible for participation if they (1) had suffered brain injury due to stroke; (2) no longer than 12 months ago; (3) were currently receiving inpatient rehabilitative care; and (4) were able to provide informed consent and understand Dutch instructions, as assessed by their physical therapist or neuropsychologist. No in-or exclusion criteria were formulated with regard to patients' motor functioning. Inclusion criteria for the control group were as follows: (1) no neurological, musculoskeletal, or cognitive impairments; (2) similar age as the stroke group; (3) able to provide informed consent and understand Dutch instructions.
Demographic characteristics of patients were obtained from their medical files and included: age, gender, days since stroke, days spent in the inpatient rehabilitation ward, lesion type (infarction, haemorrhagic), lesion location (left cortex, right cortex, bilateral cortices, stem/ cerebellar), and aphasia (yes/no). Age and sex of control participants were registered. All participants signed an informed consent. The protocol was approved by the ethical committee of the Faculty of Human Movement Sciences in Amsterdam.
Materials
The MSRS English version 181 (Appendix 4.1) was translated for the purpose of this study. This self-report scale includes 10 items. Five items relate to the construct of feeling selfconsciousness about moving (Movement Self-Consciousness) whereas the other 5 items relate specifically to conscious motor control (Conscious Motor Processing). Items are scored on a 6-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree; as in 186, 187 ). Sum scores therefore range between 5-30 for each subscale, and between 10-60 for the whole MSRS. The scale can usually be administered within 5 minutes.
Procedure
The MSRS was translated into Dutch following the recommendations of Guillemin, Bombardier, and Beaton.
188 First, three independent (native Dutch speaking) translators converted the MSRS-EV into a Dutch version and reached consensus on the best translation. Two independent translators (one native English speaker and one native Dutch speaker, both qualified English-Dutch translators) converted the consensus translation back to English. In the final, third round, a group of experts considered all translations made, and decided on the final version. Group members included individuals with knowledge of the concept of reinvestment, individuals who work with stroke patients, and all translators. The final Dutch language version of the MSRS can be found in Appendix 4.2.
Participants completed the newly translated MSRS on two occasions (T1 and T2), with one week in-between (on average 7.1 ± 3.1 days). We considered this test-retest period to be sufficiently short to minimize possible changes in patients' motor and cognitive function between measurements due to natural or therapeutic recovery, and sufficiently long to prevent recall bias. Patients with stroke always completed the scale following a regular physical or occupational therapy session, to ensure that test conditions were similar at T1 and T2. If necessary (e.g., for patients with problematic sight or aphasia), items and answer alternatives were read aloud by a research assistant.
Data analysis & statistics
All data were analysed with SPSS and AMOS software (version 21; IBM, Chicago, United States). Missing values were dealt with by imputing the median score on the respective item (2 items -or 0.1% of cases -in both groups). Outliers were removed from further analyses when the difference in total MSRS score between T1 and T2 exceeded the mean group difference by 3 z-scores or more and if additional reasons for removal were already noted when the scale was administered (e.g., suspicion of difficulty with comprehending instructions).
Structural validity
To investigate structural validity of the MSRS, confirmatory factor analysis was performed using structural equation modelling in AMOS. Confirmatory factor analysis tests whether the data fit the hypothesized two-factor model of the MSRS (i.e., that the scale contains the CMP and MS-C factors, as reported in healthy adults). 181 The data of T1 of all participants (both patients and controls) served as input for this analysis. The procedure entailed analysis of the variance-covariance matrix with maximum likelihood estimation †. 189 Items were constrained to load on the factors they should load on (either on the CMP or MS-C subscale; Appendix 4.1). As scores on the CMP subscale should be moderately correlated to scores on the MS-C subscale, 181 these factors were allowed to co-vary. Pairs of error terms within each factor were allowed to co-vary only if this improved fit of the model.
As recommended
190 the structure of the final model, standardized item-factor loadings, and several model fit tests were reported. Model fit tests were the chi-square statistic -both raw (X 2 ) and divided by its degrees of freedom (X 2 /df; both should be close to zero for good fit 191 ), goodness-of-fit and comparative fit indices (GFI and CFI; values > .90 Subsequently, measurement invariance of the overall final model was determined, to assess whether factor structure was similar for the patient and control group. 194 To this end, model fit was assessed when item-factor loadings were free to differ between patient and control groups (unconstrained testing), when item-factor loadings were equated across groups (socalled weak/metric invariance testing), and when both the item-factor loadings and the intercepts of the model were equated across groups (so-called strong invariance 194 ). When model fit is statistically similar in all these three analyses -as indicated by non-significant X 2 values and a difference in CFI of .1 or less 195 -the factor structure is similar for patients with stroke and controls. † This procedure was justified, as skewness and kurtosis of each item was well below the recommended 189 values (M skew = .62 < 2, M kurt = .25 < 7).
Construct validity
Construct validity was assessed by testing whether the MSRS could differentiate healthy controls from individuals with stroke. 196 Bonferroni corrected independent-samples t-tests were used to test the hypothesis that individuals with stroke had higher CMP and MS-C scores than healthy controls. Data collected at T1 served as input for this comparison. Significance level was set at p = .05.
Reliability
Reliability indices and measurement error were calculated for both groups separately. Internal consistency of the CMP and MS-C subscales (at T1) was assessed with Cronbach's alpha. Test-retest reliability for the total score, and for scores on the CMP and MS-C subscales was assessed with a 2-way, random effect, consistency, single measures ICC 197 ‡. Both ICC and Cronbach's alpha values should be higher than .70 for sufficient reliability. Finally, measurement error was assessed by calculation of the standard error of measurement (SEM = SD measurement1+2 ) and by calculating the minimal detectable change on the group and on the individual level (MDC group = SEM x 1.96 x √2/√n; MDC individual = SEM x 1.96 x √2).
198,199 ‡ All three variables were normally distributed in the patient group, but somewhat positively skewed in the control group (M skew = 0.9). As ICC is highly robust to slight deviations from normality 197 we chose to use the original (non-transformed) data for this analysis.
Results
One-hundred patients with stroke and one-hundred healthy peers were included. Of these 98 patients and 97 healthy controls were included in the validity and internal consistency analyses, whereas 97 patients and 91 healthy peers were included in the retest-reliability analysis (see Figure 4 .1. for details on the inclusion process). Group characteristics are presented in Table 4 .1. 
Validity
Structural validity
A total number of 195 (98 patients + 97 controls) participants were included in the analysis. The final overall model of the CFA is presented in Figure 4 .2. Model fit was best when several pairs of error terms within the MS-C subscale were co-varied (Figure 4 .2). Considerable covariance was observed between the CMP and MS-C factors (.78). Standardized item-factor loadings were all in the expected direction (i.e., positive), and of substantial magnitude (>.5). Most importantly, model fit indices were acceptable to good (X 2 (31) = 50.6, p = .015; X 2 /df = 1.63; GFI = .95; CFI = .98; SRMR = .045; RMSEA = .057, [90% CI = .026-0.085]). Subsequent tests revealed that this model demonstrated both weak (X 2 (8) = 4.6, p = .80; ΔCFI = .007) and strong measurement invariance (X 2 (11) = 15.9, p = .14; ΔCFI = .01). Thus, factor analysis confirmed the hypothesized two-factor structure of the MSRS, both for the patient and control group.
Construct validity
Summed reinvestment scores of both groups are presented in Table 4 .2. The hypothesis for construct validity was supported by independent-samples t-tests. Stroke patients scored higher on the MSRS than controls, both with regard to the CMP (t(183.8) = 13.5, p < .001, d = 1.9, 95% CI = [8.7 12.7]), and MS-C subscale (t(172.9) = 10.3, p < .001, d = 1.5, 95% CI = [6.0 9.8]). Additional t-tests showed that CMP scores were higher than MS-C scores, both for patients (t(97) = 10.6, p < . Table 4 .3 lists all reliability measures. For the control group, internal consistency was satisfactory. For patients, Cronbach's alpha of the CMP-subscale was somewhat below the threshold of .70, but still of substantial magnitude §. Test-retest indices showed a similar pattern of results, with the CMP-subscale scoring slightly below cut-off in the patient group (.70). Observation of the range of scores on this subscale revealed that limited variance may partially account for this: on T1, all patients scored above 5 on the CMP subscale. § Additional analysis of the inter-item correlation matrix revealed that item 1 ("I remember the times when my movements have failed me") correlated poorly with items 3 (r = .16) and 9 (r = .11), and demonstrated weak item-total correlation (i.e., r < .3). However, it was decided not to remove this item, considering that confirmatory factor analysis showed item 1 to have satisfactory factor loading (.61), and since removal of this item would only slightly improve Cronbach's alpha of the CMP subscale (α = .67). The SEM and minimal detectable change were greater for patients than for controls. Specifically, on an individual level the minimal detectable change for the total MSRS score was almost twice as large in patients (12.5) as in controls (6.9). As the total score can range between 10 and 60, it therefore seems that individual changes in MSRS score of 25% or more can be reliably detected in patients with stroke. On group level, however, the minimal detectable change for the total scale and the two subscales was adequate in both groups (i.e., ≤ 1.2). 
Reliability
CMP
MSC
Discussion
It has been proposed that the tendency to consciously control motor actions by 'reinvesting' attentional resources delays motor recovery after stroke. 28, 93 As a first step to investigate this hypothesis, this study validated (a Dutch language version of ) the Movement-Specific Reinvestment Scale for use in an inpatient stroke population and healthy age-matched peers. Structural validity was supported by factor analysis, which confirmed the two-factor structure obtained by earlier studies within healthy adults. 180, 181 In addition, construct validity was verified, as the MSRS successfully differentiated inpatient stroke patients from healthy peers. Furthermore, test-retest reliability and internal consistency were adequate in both groups. Taken together, the MSRS seems a valid and reliable instrument to measure reinvestment tendencies of inpatient patients with stroke and healthy age-matched controls.
This study was the first to assess the validity of the MSRS to measure reinvestment tendencies after stroke. Similar to earlier studies, 180,181 when administered to stroke patients, the MSRS encompasses two latent factors, with 5 items relating to one's tendency to engage in conscious motor control (CMP subscale) and 5 measuring the degree to which one feels self-conscious about one's style of moving (MS-C subscale). Tests of construct validity showed that patients with stroke scored higher than controls on both these subscales, reproducing findings with the English MSRS within a chronic stroke population. 28 Further support for the validity of the MSRS's two-factor structure stems from the finding that patients with stroke scored higher on the CMP subscale than on the MS-C subscale, replicating earlier findings with chronic stroke patients.
28,29 and patients with Parkinson's disease. 200 It is doubtful that both subscales are of equal clinical relevance, though. Theoretically, one would expect the CMP subscale to be of more relevance than the MS-C subscale, as the former directly concerns one's motor control preferences, whereas the latter merely gauges whether one feels awkward about one's style of moving. Indeed, there is some evidence to support this hypothesis. For instance, higher CMP scores have been found to be uniquely associated with more severe motor impairments in people with stroke, 28 with an increased risk of falling in healthy elderly, 180 with duration of Parkinson's disease, 200 and with more self-reported knee pain in healthy adults.
187 Since no such associations have been reported for individuals' MS-C scores, researchers and rehabilitation therapists may be especially interested in patients' scores on the CMP subscale. Further exploration of the unique associations between MS-C and CMP scores and motor behaviour after stroke is needed.
For the patient group, test-retest reliability indices of the total scale and MS-C subscale were comparable to those reported by Kleynen et al. 29 It seems that in this study the CMP subscale is somewhat less reliable, however. This might be due to the fact that this inpatient stroke population generally is in a less 'stable' situation than the chronic stroke population studied by Kleynen and colleagues. In addition, as noted earlier, low variance in scores on the CMP subscale may have attenuated test-retest reliability. Finally, the use of a 6-point Likert scale (instead of a dichotomous one) may have compromised reliability, as it may have been somewhat more difficult to complete. For the stroke group, internal consistency values of both subscales were similar to those of English and French versions of the MSRS when tested in healthy adults. 181, 201 With regard to the control group, both retest reliability and internal consistency were satisfactory to good, replicating findings obtained within young healthy adults.
181
Next to validity and reliability, the utility of the MSRS depends on its measurement error. In this study, although the minimal detectable change of the total scale (12.5 points or 25% of total scale range) was slightly better than the measurement error reported by Kleynen et al. 29 (3 points or 27% of total scale range), it was still relatively large. However, the minimal detectable change was considerably better when assessed on a group level (1.2 points for the total scale, and 0.8 for each subscale). This suggests that the MSRS is suitable to compare reinvestment tendencies across different groups, but is less suitable for tracking individual changes in reinvestment after stroke. In other words, the MSRS may be especially useful for scientific purposes, but needs further refinement for clinical applications. It is unclear how measurement error for the control group compares to earlier work, as this is the first study to report on the minimal detectable change in reinvestment score within healthy (elderly) individuals. Nonetheless, the minimal detectable change for this group seemed adequate both on a group and individual level.
A strength of the present study is that the study population was representative for the general stroke population that is admitted for clinical rehabilitation in a rehabilitation center in the Netherlands. All inpatient people with stroke were screened for participation (n=116). About 86% of these participated, among whom a considerable number of aphasic patients (13%). Of note, a limitation is that we assessed the validity and reliability of the MSRS within a Dutch stroke population. Nonetheless, our results likely also hold true for other stroke populations, as the scale was translated in accordance with cross-cultural validation guidelines [20] . A more poignant limitation of the MSRS is that it seems less useful for patients with severe aphasia and/or substantial cognitive impairments, as they made up the majority of patients who were excluded from participation. Also, a practical limitation of the MSRS is that questions and answer possibilities need to be read aloud for many patients (e.g., 33% in our study), mostly due to problems with vision (e.g. neglect) or aphasia. Relatedly, a limitation of the present study is that we did not specifically assess cognitive and motor abilities of patients. As our in-and exclusion criteria were quite lenient, it is likely that there was large heterogeneity in terms of cognitive and motor functioning in the patient population. Even so, the MSRS was found to be reliable.
Finally, although technically beyond the scope of this study, our data allowed an interesting side-speculation. That is, two observations from our data may nuance the idea that patients' increased tendency to reinvest is the result of the predominance of explicit motor learning strategies 43,178 within current rehabilitation practice. 28 First, a considerable number of patients (± 25%) were tested within the first two weeks since the start of rehabilitation. Second, no significant association was observed between the time spent in rehabilitation at T1 and reinvestment score (r < .3, p > .1), suggesting that reinvestment does not change substantially throughout rehabilitation. Based on this, we speculate that reinvestment is not necessarily a strategy patients gradually acquire in the course of rehabilitation. Instead, patients with stroke may already have become highly prone to reinvest even before rehabilitation commences, and remain so throughout the rehabilitation period. Whether this impedes patients' motor recovery (as argued by Orrell et al. 28 ) remains an open question. In this regard, the results of Stillman and co-workers are worth mentioning. 202 They reported that healthy (young and old) people who are more predisposed to be mindful (or: " to stay attentive and receptive to events and experiences taking place in the present and thus disengage from habitual actions and thought tendencies", p. 141) have a reduced implicit motor learning ability. Considering the apparent similarities between the concepts of reinvestment (or more specifically: conscious motor processing) and mindfulness, one may speculate that many stroke patients with a strong disposition to reinvest are less able to learn motor skills implicitly. This would be also in line with reports that people with higher reinvestment tendencies are more likely to engage in explicit motor learning. 203 Future research should explore this hypothesis, by further mapping the relation between motor recovery and dispositional reinvestment post-stroke.
Conclusion
We conclude that the MSRS is a valid and reliable tool to measure reinvestment after stroke. The clinical usefulness of this tool for individual patients remains to be determined though. In order to establish this, future studies need to assess (1) whether reinvestment indeed impairs motor functioning post-stroke, and (2) whether the MSRS is accurate enough to measure clinically meaningful changes in reinvestment over time in individual patients.
Acknowledgements
We would like to thank Christa de Jonge, Charlotte Postma, Nynke Bos, and Mette van Kruijsbergen for their contributions to the data collection, Jacinta Kal and Steven Barker for their aid in the translation process, and dr. Wouter Weeda for his valuable statistical advice. refer to the subscale Conscious Motor Processing (CMP);
